About Us


FlexPerc Medical (also known as phenoMapper) was founded in 2019 to advance local cancer therapy to address the needs for multi-disciplinary treatment approach for cancer patients. 


We started our journey with research and development of our patent-pending personalized decision support and  planning software for local cancer therapy. One of our research findings was the need for precise device positioning to achieve the best outcomes in local cancer therapy. This finding led us to the development of a self-driving robotic platform for local cancer therapy. 

Our mission is to help interventionists to achieve the best possible outcomes in local cancer therapy